Marc Samsky, MD, FACC
Assistant Professor
Research & Publications
Biography
News
Coauthors
Selected Publications
- American Heart Association Cardiogenic Shock Registry: Design and Implementation.Morrow D, Jessup M, Abraham W, Acker M, Aringo A, Batchelor W, Chikwe J, Costello S, Drakos S, Farmer S, Gelijns A, Gillette N, Hochman J, Isler M, Kapur N, Kilic A, Kormos R, Lewis E, Lindenfeld J, Lombardi P, Mancini D, Rao S, Rutan C, Samsky M, Krucoff M. American Heart Association Cardiogenic Shock Registry: Design and Implementation. Circulation Cardiovascular Quality And Outcomes 2024, e010637. PMID: 38887950, DOI: 10.1161/circoutcomes.123.010637.
- Association Between Frailty and Management and Outcomes of Acute Myocardial Infarction Complicated by Cardiogenic ShockJamil Y, Park D, Rao S, Ahmad Y, Sikand N, Bosworth H, Coles T, Damluji A, Nanna M, Samsky M. Association Between Frailty and Management and Outcomes of Acute Myocardial Infarction Complicated by Cardiogenic Shock. JACC Advances 2024, 3: 100949. DOI: 10.1016/j.jacadv.2024.100949.
- Comparative analysis of treatment options for chronic heart failure and depression: a systematic review and Bayesian network meta-analysisSoleimani H, Nasrollahizadeh A, Hajiqasemi M, Ebrahimzade M, Taheri H, Ebrahimi P, Ashraf H, Samsky M, Hosseini K. Comparative analysis of treatment options for chronic heart failure and depression: a systematic review and Bayesian network meta-analysis. Heart Failure Reviews 2024, 1-12. PMID: 38613598, DOI: 10.1007/s10741-024-10403-z.
- Frailty and In-Hospital Outcomes for Management of Cardiogenic Shock without Acute Myocardial InfarctionPark D, Jamil Y, Ahmad Y, Coles T, Bosworth H, Sikand N, Davila C, Babapour G, Damluji A, Rao S, Nanna M, Samsky M. Frailty and In-Hospital Outcomes for Management of Cardiogenic Shock without Acute Myocardial Infarction. Journal Of Clinical Medicine 2024, 13: 2078. PMID: 38610842, PMCID: PMC11012362, DOI: 10.3390/jcm13072078.
- The management of heart failure cardiogenic shock: an international RAND appropriateness panelWilliams S, Kalakoutas A, Olusanya S, Schrage B, Tavazzi G, Carnicelli A, Montero S, Vandenbriele C, Luk A, Lim H, Bhagra S, Ott S, Farrero M, Samsky M, Kennedy J, Sen S, Agrawal R, Rampersad P, Coniglio A, Pappalardo F, Barnett C, Proudfoot A. The management of heart failure cardiogenic shock: an international RAND appropriateness panel. Critical Care 2024, 28: 105. PMID: 38566212, PMCID: PMC10988801, DOI: 10.1186/s13054-024-04884-5.
- Association of cardiovascular diseases with cognitive performance in older adultsPark D, Jamil Y, Babapour G, Kim J, Campbell G, Akman Z, Kochar A, Sen S, Samsky M, Sikand N, Frampton J, Damluji A, Nanna M. Association of cardiovascular diseases with cognitive performance in older adults. American Heart Journal 2024, 273: 10-20. PMID: 38575050, PMCID: PMC11162917, DOI: 10.1016/j.ahj.2024.03.016.
- Prognostic Impact of Repeated NT-proBNP Measurements in Patients With Heart Failure With Reduced Ejection FractionFuery M, Leifer E, Samsky M, Sen S, O'Connor C, Fiuzat M, Ezekowitz J, Piña I, Whellan D, Mark D, Felker G, Desai N, Januzzi J, Ahmad T. Prognostic Impact of Repeated NT-proBNP Measurements in Patients With Heart Failure With Reduced Ejection Fraction. JACC Heart Failure 2023, 12: 479-487. PMID: 38127049, DOI: 10.1016/j.jchf.2023.11.007.
- Safety of sodium‐glucose cotransporter 2 inhibitors drugs among heart failure patients: a systematic review and meta‐analysisSoleimani H, Saeedian B, Pasebani Y, Babajani N, Yeganeh A, Bahirai P, Navid H, Amin A, Samsky M, Nanna M, Hosseini K. Safety of sodium‐glucose cotransporter 2 inhibitors drugs among heart failure patients: a systematic review and meta‐analysis. ESC Heart Failure 2023, 11: 637-648. PMID: 38124239, PMCID: PMC10966218, DOI: 10.1002/ehf2.14633.
- Is There a Role for Risk Scores in the Management of Heart Failure? ∗Abou Alaiwi S, Samsky M, Ahmad T. Is There a Role for Risk Scores in the Management of Heart Failure? ∗. JACC Heart Failure 2023, 12: 197-198. PMID: 38069995, DOI: 10.1016/j.jchf.2023.10.007.
- Standardized Definitions for Cardiogenic Shock Research and Mechanical Circulatory Support Devices: Scientific Expert Panel From the Shock Academic Research Consortium (SHARC)Waksman R, Pahuja M, van Diepen S, Proudfoot A, Morrow D, Spitzer E, Nichol G, Weisfeldt M, Moscucci M, Lawler P, Mebazaa A, Fan E, Dickert N, Samsky M, Kormos R, Piña I, Zuckerman B, Farb A, Sapirstein J, Simonton C, West N, Damluji A, Gilchrist I, Zeymer U, Thiele H, Cutlip D, Krucoff M, Abraham W. Standardized Definitions for Cardiogenic Shock Research and Mechanical Circulatory Support Devices: Scientific Expert Panel From the Shock Academic Research Consortium (SHARC). Circulation 2023, 148: 1113-1126. PMID: 37782695, PMCID: PMC11025346, DOI: 10.1161/circulationaha.123.064527.
- Electronic health record alerts for management of heart failure with reduced ejection fraction in hospitalized patients: the PROMPT-AHF trialGhazi L, Yamamoto Y, Fuery M, O'Connor K, Sen S, Samsky M, Riello R, Dhar R, Huang J, Olufade T, McDermott J, Inzucchi S, Velazquez E, Wilson F, Desai N, Ahmad T. Electronic health record alerts for management of heart failure with reduced ejection fraction in hospitalized patients: the PROMPT-AHF trial. European Heart Journal 2023, 44: 4233-4242. PMID: 37650264, DOI: 10.1093/eurheartj/ehad512.
- Electronic Health Record Embedded Strategies for Improving Care of Patients With Heart FailureFuery M, Kadhim B, Samsky M, Freeman J, Clark K, Desai N, Wilson F, Ahmed T, Ahmad T. Electronic Health Record Embedded Strategies for Improving Care of Patients With Heart Failure. Current Heart Failure Reports 2023, 20: 280-286. PMID: 37552356, DOI: 10.1007/s11897-023-00614-0.
- Patient Perspectives on Digital Interventions to Manage Heart Failure Medications: The VITAL-HF PilotSamsky M, Leverty R, Gray J, Davis A, Fisher B, Govil A, Stanis T, DeVore A. Patient Perspectives on Digital Interventions to Manage Heart Failure Medications: The VITAL-HF Pilot. Journal Of Clinical Medicine 2023, 12: 4676. PMID: 37510791, PMCID: PMC10380884, DOI: 10.3390/jcm12144676.
- The Use of the Multisensor HeartLogic Algorithm for Heart Failure Remote Monitoring in Patients With Left Ventricular Assist DevicesLerman J, Cyr D, Chiswell K, Tobin R, Fudim M, Pokorney S, Mentz R, Samsky M. The Use of the Multisensor HeartLogic Algorithm for Heart Failure Remote Monitoring in Patients With Left Ventricular Assist Devices. ASAIO Journal 2023, 69: e351-e353. PMID: 37097988, DOI: 10.1097/mat.0000000000001946.
- Risk Prediction for Heart Failure Patients Admitted to the Intensive Care Unit Insights From REVeAL-HFO’Connor K, Yamamoto Y, Sen S, Samsky M, Wilson F, Desai N, Ahmad T, Fuery M. Risk Prediction for Heart Failure Patients Admitted to the Intensive Care Unit Insights From REVeAL-HF. JACC Heart Failure 2023, 11: 727-728. PMID: 37052546, DOI: 10.1016/j.jchf.2023.01.021.
- WHAT IS THE VALUE OF REPEATED NT-PROBNP MEASUREMENTS IN CHRONIC HEART FAILURE WITH REDUCED EJECTION FRACTION?Fuery M, Leifer E, Samsky M, Sen S, O'Connor C, Fiuzat M, Ezekowitz J, Pina I, Whellan D, Mark D, Felker G, Desai N, Januzzi J, Ahmad T. WHAT IS THE VALUE OF REPEATED NT-PROBNP MEASUREMENTS IN CHRONIC HEART FAILURE WITH REDUCED EJECTION FRACTION? Journal Of The American College Of Cardiology 2023, 81: 624. DOI: 10.1016/s0735-1097(23)01068-9.
- Use of Structured Electronic Health Records Data Elements for the Development of Computable Phenotypes to Identify Potential Adverse Events Associated with Intravenous Immunoglobulin InfusionHurst J, Brucker A, Zhao C, Driscoll H, Hostetler H, Phillips M, Rosenberg B, Samsky M, Smith I, Reller M, Strouse J, Zhou C, Dores G, Wong H, Goldstein B. Use of Structured Electronic Health Records Data Elements for the Development of Computable Phenotypes to Identify Potential Adverse Events Associated with Intravenous Immunoglobulin Infusion. Drug Safety 2023, 46: 309-318. PMID: 36826707, DOI: 10.1007/s40264-023-01276-6.
- Pragmatic trial of messaging to providers about treatment of acute heart failure: The PROMPT-AHF trialGhazi L, O'Connor K, Yamamoto Y, Fuery M, Sen S, Samsky M, Riello R, Huang J, Olufade T, McDermott J, Inzucchi S, Velazquez E, Wilson F, Desai N, Ahmad T. Pragmatic trial of messaging to providers about treatment of acute heart failure: The PROMPT-AHF trial. American Heart Journal 2022, 257: 111-119. PMID: 36493842, DOI: 10.1016/j.ahj.2022.12.002.
- Network Meta-Analysis Comparing Angiotensin Receptor-Neprilysin Inhibitors, Angiotensin Receptor Blockers, and Angiotensin-Converting Enzyme Inhibitors in Heart Failure With Reduced Ejection FractionPark D, An S, Attanasio S, Jolly N, Malhotra S, Doukky R, Samsky M, Sen S, Ahmad T, Nanna M, Vij A. Network Meta-Analysis Comparing Angiotensin Receptor-Neprilysin Inhibitors, Angiotensin Receptor Blockers, and Angiotensin-Converting Enzyme Inhibitors in Heart Failure With Reduced Ejection Fraction. The American Journal Of Cardiology 2022, 187: 84-92. PMID: 36459752, PMCID: PMC10958453, DOI: 10.1016/j.amjcard.2022.10.026.
- Position Statement on Vascular Access Safety for Percutaneous Devices in AMI Complicated by Cardiogenic ShockDamluji A, Tehrani B, Sinha S, Samsky M, Henry T, Thiele H, West N, Senatore F, Truesdell A, Dangas G, Smilowitz N, Amin A, deVore A, Moazami N, Cigarroa J, Rao S, Krucoff M, Morrow D, Gilchrist I. Position Statement on Vascular Access Safety for Percutaneous Devices in AMI Complicated by Cardiogenic Shock. JACC Cardiovascular Interventions 2022, 15: 2003-2019. PMID: 36265932, PMCID: PMC10312149, DOI: 10.1016/j.jcin.2022.08.041.
- Leveraging “Big Data” for the Design and Execution of Clinical TrialsGreene S, Samsky M, Hernandez A. Leveraging “Big Data” for the Design and Execution of Clinical Trials. 2022, 2241-2262. DOI: 10.1007/978-3-319-52636-2_161.
- Sacubitril/Valsartan in Advanced Heart Failure Shattering the Paradigm to Focus on Real LIFE ∗Samsky MD, Sen S. Sacubitril/Valsartan in Advanced Heart Failure Shattering the Paradigm to Focus on Real LIFE ∗. JACC Heart Failure 2022, 10: 457-458. PMID: 35772854, DOI: 10.1016/j.jchf.2022.05.011.
- Review of Cardiogenic Shock After Acute Myocardial Infarction—ReplySamsky M, Rao S. Review of Cardiogenic Shock After Acute Myocardial Infarction—Reply. JAMA 2022, 327: 879-879. PMID: 35230396, DOI: 10.1001/jama.2021.25178.
- SCAI SHOCK Stage Classification Expert Consensus Update: A Review and Incorporation of Validation Studies This statement was endorsed by the American College of Cardiology (ACC), American College of Emergency Physicians (ACEP), American Heart Association (AHA), European Society of Cardiology (ESC) Association for Acute Cardiovascular Care (ACVC), International Society for Heart and Lung Transplantation (ISHLT), Society of Critical Care Medicine (SCCM), and Society of Thoracic Surgeons (STS) in December 2021.Naidu S, Baran D, Jentzer J, Hollenberg S, van Diepen S, Basir M, Grines C, Diercks D, Hall S, Kapur N, Kent W, Rao S, Samsky M, Thiele H, Truesdell A, Henry T. SCAI SHOCK Stage Classification Expert Consensus Update: A Review and Incorporation of Validation Studies This statement was endorsed by the American College of Cardiology (ACC), American College of Emergency Physicians (ACEP), American Heart Association (AHA), European Society of Cardiology (ESC) Association for Acute Cardiovascular Care (ACVC), International Society for Heart and Lung Transplantation (ISHLT), Society of Critical Care Medicine (SCCM), and Society of Thoracic Surgeons (STS) in December 2021. Journal Of The American College Of Cardiology 2022, 79: 933-946. PMID: 35115207, DOI: 10.1016/j.jacc.2022.01.018.
- SCAI SHOCK Stage Classification Expert Consensus Update: A Review and Incorporation of Validation Studies This statement was endorsed by the American College of Cardiology (ACC), American College of Emergency Physicians (ACEP), American Heart Association (AHA), European Society of Cardiology (ESC) Association for Acute Cardiovascular Care (ACVC), International Society for Heart and Lung Transplantation (ISHLT), Society of Critical Care Medicine (SCCM), and Society of Thoracic Surgeons (STS) in December 2021.Naidu S, Baran D, Jentzer J, Hollenberg S, van Diepen S, Basir M, Grines C, Diercks D, Hall S, Kapur N, Kent W, Rao S, Samsky M, Thiele H, Truesdell A, Henry T. SCAI SHOCK Stage Classification Expert Consensus Update: A Review and Incorporation of Validation Studies This statement was endorsed by the American College of Cardiology (ACC), American College of Emergency Physicians (ACEP), American Heart Association (AHA), European Society of Cardiology (ESC) Association for Acute Cardiovascular Care (ACVC), International Society for Heart and Lung Transplantation (ISHLT), Society of Critical Care Medicine (SCCM), and Society of Thoracic Surgeons (STS) in December 2021. Journal Of The Society For Cardiovascular Angiography & Interventions 2022, 1: 100008. DOI: 10.1016/j.jscai.2021.100008.
- Race Differences in Quality of Life following a Palliative Care Intervention in Patients with Advanced Heart Failure: Insights from the Palliative Care in Heart Failure TrialTobin R, Samsky M, Kuchibhatla M, O'Connor C, Fiuzat M, Warraich H, Anstrom K, Granger B, Mark D, Tulsky J, Rogers J, Mentz R, Johnson K. Race Differences in Quality of Life following a Palliative Care Intervention in Patients with Advanced Heart Failure: Insights from the Palliative Care in Heart Failure Trial. Journal Of Palliative Medicine 2021, 25: 296-300. PMID: 34851740, PMCID: PMC9022123, DOI: 10.1089/jpm.2021.0220.
- Contemporary Management of Cardiogenic Shock: A RAND Appropriateness Panel ApproachProudfoot A, Kalakoutas A, Meade S, Griffiths M, Basir M, Burzotta F, Chih S, Fan E, Haft J, Ibrahim N, Kruit N, Lim H, Morrow D, Nakata J, Price S, Rosner C, Roswell R, Samaan M, Samsky M, Thiele H, Truesdell A, van Diepen S, Voeltz M, Irving P. Contemporary Management of Cardiogenic Shock: A RAND Appropriateness Panel Approach. Circulation Heart Failure 2021, 14: e008635. PMID: 34807723, PMCID: PMC8692411, DOI: 10.1161/circheartfailure.121.008635.
- Cardiogenic Shock After Acute Myocardial InfarctionSamsky M, Morrow D, Proudfoot A, Hochman J, Thiele H, Rao S. Cardiogenic Shock After Acute Myocardial Infarction. JAMA 2021, 326: 1840-1850. PMID: 34751704, PMCID: PMC9661446, DOI: 10.1001/jama.2021.18323.
- Polyvascular disease and increased risk of cardiovascular events in patients with type 2 diabetes: Insights from the EXSCEL trialSamsky M, Mentz R, Stebbins A, Lokhnygina Y, Aday A, Pagidipati N, Jones W, Katona B, Patel M, Holman R, Hernandez A, Gutierrez J. Polyvascular disease and increased risk of cardiovascular events in patients with type 2 diabetes: Insights from the EXSCEL trial. Atherosclerosis 2021, 338: 1-6. PMID: 34741929, PMCID: PMC8702379, DOI: 10.1016/j.atherosclerosis.2021.10.011.
- Clinical Effectiveness of Sacubitril/Valsartan Among Patients Hospitalized for Heart Failure With Reduced Ejection FractionGreene SJ, Choi S, Lippmann SJ, Mentz RJ, Greiner MA, Hardy NC, Hammill BG, Luo N, Samsky MD, Heidenreich PA, Laskey WK, Yancy CW, Peterson PN, Curtis LH, Hernandez AF, Fonarow GC, O'Brien EC. Clinical Effectiveness of Sacubitril/Valsartan Among Patients Hospitalized for Heart Failure With Reduced Ejection Fraction. Journal Of The American Heart Association 2021, 10: e021459. PMID: 34350772, PMCID: PMC8475054, DOI: 10.1161/jaha.121.021459.
- Association of Heart Failure With Outcomes Among Patients With Peripheral Artery Disease: Insights From EUCLIDSamsky M, Hellkamp A, Hiatt W, Fowkes F, Baumgartner I, Berger J, Katona B, Mahaffey K, Norgren L, Blomster J, Rockhold F, DeVore A, Patel M, Jones W. Association of Heart Failure With Outcomes Among Patients With Peripheral Artery Disease: Insights From EUCLID. Journal Of The American Heart Association 2021, 10: e018684. PMID: 34056910, PMCID: PMC8477881, DOI: 10.1161/jaha.120.018684.
- Randomized Placebo-Controlled Trial of Ferric Carboxymaltose in Heart Failure With Iron DeficiencyMentz R, Ambrosy A, Ezekowitz J, Lewis G, Butler J, Wong Y, De Pasquale C, Troughton R, O’Meara E, Rockhold F, Garg J, Samsky M, Leloudis D, Dugan M, Mundy L, Hernandez A, Investigators O. Randomized Placebo-Controlled Trial of Ferric Carboxymaltose in Heart Failure With Iron Deficiency. Circulation Heart Failure 2021, 14: e008100. PMID: 34003690, PMCID: PMC8136455, DOI: 10.1161/circheartfailure.120.008100.
- The Impact of Adverse Events on Functional Capacity and Quality of Life After HeartWare Ventricular Assist Device ImplantationSamsky M, Milano C, Pamboukian S, Slaughter M, Birks E, Boyce S, Najjar S, Itoh A, Reid B, Mokadam N, Aaronson K, Pagani F, Rogers J. The Impact of Adverse Events on Functional Capacity and Quality of Life After HeartWare Ventricular Assist Device Implantation. ASAIO Journal 2021, 67: 1159-1162. PMID: 33927085, PMCID: PMC8478694, DOI: 10.1097/mat.0000000000001378.
- Venous thromboembolism among patients hospitalized with COVID-19 at Veterans Health Administration HospitalsGutierrez J, Samsky M, Schulteis R, Gu L, Swaminathan R, Aday A, Rao S. Venous thromboembolism among patients hospitalized with COVID-19 at Veterans Health Administration Hospitals. American Heart Journal 2021, 237: 1-4. PMID: 33745899, PMCID: PMC7970480, DOI: 10.1016/j.ahj.2021.03.010.
- Patterns of Change in Individual Domains of the Kansas City Cardiomyopathy Questionnaire With a Palliative Care Intervention for Patients With Advanced Heart Failure: Insights from PAL-HFWan L, Samsky M, O'Connor C, Stebbins A, Alhanti B, Warraich H, Johnson K, Anstrom K, Fiuzat M, Granger B, Mark D, Tulsky J, Rogers J, Mentz R. Patterns of Change in Individual Domains of the Kansas City Cardiomyopathy Questionnaire With a Palliative Care Intervention for Patients With Advanced Heart Failure: Insights from PAL-HF. Journal Of Cardiac Failure 2021, 27: 1476-1478. PMID: 33647475, PMCID: PMC8387495, DOI: 10.1016/j.cardfail.2021.02.007.
- Efficacy and Safety of Sacubitril/Valsartan in High-Risk Patients in the PIONEER-HF TrialBerg DD, Samsky MD, Velazquez EJ, Duffy CI, Gurmu Y, Braunwald E, Morrow DA, DeVore AD. Efficacy and Safety of Sacubitril/Valsartan in High-Risk Patients in the PIONEER-HF Trial. Circulation Heart Failure 2021, 14: e007034. PMID: 33530704, PMCID: PMC7908815, DOI: 10.1161/circheartfailure.120.007034.
- Leveraging “Big Data” for the Design and Execution of Clinical TrialsGreene S, Samsky M, Hernandez A. Leveraging “Big Data” for the Design and Execution of Clinical Trials. 2021, 1-23. DOI: 10.1007/978-3-319-52677-5_161-1.
- Contemporary Use of Venoarterial Extracorporeal Membrane Oxygenation: Insights from the Multicenter RESCUE RegistryLoungani R, Fudim M, Ranney D, Kochar A, Samsky M, Bonadonna D, Itoh A, Takayama H, Takeda K, Wojdyla D, DeVore A, Daneshmand M. Contemporary Use of Venoarterial Extracorporeal Membrane Oxygenation: Insights from the Multicenter RESCUE Registry. Journal Of Cardiac Failure 2021, 27: 327-337. PMID: 33347997, PMCID: PMC8008981, DOI: 10.1016/j.cardfail.2020.11.026.
- Abstract 15771: Recovery of Left Ventricular Function on Lvad Support is Associated With Improved OutcomesOlsen C, Mandawat A, Triana T, Samsky M, Chiswell K, Karra R. Abstract 15771: Recovery of Left Ventricular Function on Lvad Support is Associated With Improved Outcomes. Circulation 2020, 142 DOI: 10.1161/circ.142.suppl_3.15771.
- Abstract 14837: Social Determinants of Health and Outcomes in Patients With Advanced Heart Failure: Findings From PAL-HFBlumer V, Rogers J, OConnor C, Clare R, Mark D, Fiuzat M, Granger B, Patel C, Samsky M, Johnson K, Tulsky J, Mentz R. Abstract 14837: Social Determinants of Health and Outcomes in Patients With Advanced Heart Failure: Findings From PAL-HF. Circulation 2020, 142 DOI: 10.1161/circ.142.suppl_3.14837.
- Cardiac safety research consortium “shock II” think tank report: Advancing practical approaches to generating evidence for the treatment of cardiogenic shockSamsky M, Krucoff M, Morrow D, Abraham W, Aguel F, Althouse A, Chen E, Cigarroa J, DeVore A, Farb A, Gilchrist I, Henry T, Hochman J, Kapur N, Morrow V, Ohman E, O'Neill W, Piña I, Proudfoot A, Sapirstein J, Seltzer J, Senatore F, Shinnar M, Simonton C, Tehrani B, Thiele H, Truesdell A, Waksman R, Rao S. Cardiac safety research consortium “shock II” think tank report: Advancing practical approaches to generating evidence for the treatment of cardiogenic shock. American Heart Journal 2020, 230: 93-97. PMID: 33011148, PMCID: PMC7704747, DOI: 10.1016/j.ahj.2020.09.015.
- Contemporary Use of Veno-arterial Extracorporeal Membrane Oxygenation: Insights from the Multicenter Rescue RegistryLoungani R, Fudim M, Ranney D, Kochar A, Samsky M, Bonadonna D, Itoh A, Takayama H, Takeda K, Wojdyla D, DeVore A, Daneshmand M. Contemporary Use of Veno-arterial Extracorporeal Membrane Oxygenation: Insights from the Multicenter Rescue Registry. Journal Of Cardiac Failure 2020, 26: s139. DOI: 10.1016/j.cardfail.2020.09.404.
- Heart Failure Clinical Trial Operations During the COVID-19 Pandemic: Results from a Multicenter SurveySamsky M, DeVore A, McIlvennan C, Granger C, Granger B, Hernandez A, Felker G, Fonarow G, Albert N, Piña I, Lanfear D, Allen L. Heart Failure Clinical Trial Operations During the COVID-19 Pandemic: Results from a Multicenter Survey. Circulation Heart Failure 2020, 13: e007456. PMID: 32700547, PMCID: PMC7494552, DOI: 10.1161/circheartfailure.120.007456.
- Patient Perceptions and Familiarity With Medical Therapy for Heart FailureSamsky M, Lin L, Greene S, Lippmann S, Peterson P, Heidenreich P, Laskey W, Yancy C, Greiner M, Hardy N, Kavati A, Park S, Mentz R, Fonarow G, O’Brien E. Patient Perceptions and Familiarity With Medical Therapy for Heart Failure. JAMA Cardiology 2020, 5: 292-299. PMID: 31734700, PMCID: PMC6865328, DOI: 10.1001/jamacardio.2019.4987.
- Clinical and regulatory landscape for cardiogenic shock: A report from the Cardiac Safety Research Consortium ThinkTank on cardiogenic shockSamsky M, Krucoff M, Althouse A, Abraham W, Adamson P, Aguel F, Bilazarian S, Dangas G, Gilchrist I, Henry T, Hochman J, Kapur N, Laschinger J, Masters R, Michelson E, Morrow D, Morrow V, Ohman E, Pina I, Proudfoot A, Rogers J, Sapirstein J, Senatore F, Stockbridge N, Thiele H, Truesdell A, Waksman R, Rao S. Clinical and regulatory landscape for cardiogenic shock: A report from the Cardiac Safety Research Consortium ThinkTank on cardiogenic shock. American Heart Journal 2019, 219: 1-8. PMID: 31707323, PMCID: PMC7604661, DOI: 10.1016/j.ahj.2019.10.006.
- Clinical Effectiveness of Sacubitril/valsartan among Patients Hospitalized for Heart Failure with Reduced Ejection FractionGreene S, Lippmann S, Mentz R, Greiner M, Hardy N, Chang C, Hammill B, Luo N, Samsky M, Heidenreich P, Laskey W, Yancy C, Peterson P, Curtis L, Hernandez A, Fonarow G, O'Brien E. Clinical Effectiveness of Sacubitril/valsartan among Patients Hospitalized for Heart Failure with Reduced Ejection Fraction. Journal Of Cardiac Failure 2019, 25: 937. DOI: 10.1016/j.cardfail.2019.11.003.
- Review: In HF with iron deficiency, iron supplementation reduces HF admissions and improves cardiac function.Samsky M, Newby L. Review: In HF with iron deficiency, iron supplementation reduces HF admissions and improves cardiac function. Annals Of Internal Medicine 2019, 171: jc19. PMID: 31426062, PMCID: PMC7595436, DOI: 10.7326/acpj201908200-019.
- Patterns of Change in Quality of Life with a Palliative Care Intervention for Patients with Advanced Heart Failure: Insights from PAL-HFWan L, O'Connor C, Stebbins A, Alhanti B, Samsky M, Warraich H, Johnson K, Anstrom K, Fiuzat M, Granger B, Mark D, Tulsky J, Rogers J, Mentz R. Patterns of Change in Quality of Life with a Palliative Care Intervention for Patients with Advanced Heart Failure: Insights from PAL-HF. Journal Of Cardiac Failure 2019, 25: s154-s155. DOI: 10.1016/j.cardfail.2019.07.444.
- Trends in Readmissions and Length of Stay for Patients Hospitalized With Heart Failure in Canada and the United StatesSamsky M, Ambrosy A, Youngson E, Liang L, Kaul P, Hernandez A, Peterson E, McAlister F. Trends in Readmissions and Length of Stay for Patients Hospitalized With Heart Failure in Canada and the United States. JAMA Cardiology 2019, 4: 444-453. PMID: 30969316, PMCID: PMC6537806, DOI: 10.1001/jamacardio.2019.0766.
- When VAD Things Happen to Good PeopleSamsky M, Rogers J. When VAD Things Happen to Good People. Circulation 2017, 137: 907-909. PMID: 28847898, DOI: 10.1161/circulationaha.117.031081.
- Trajectory of Congestion Metrics by Ejection Fraction in Patients With Acute Heart Failure (from the Heart Failure Network)Ambrosy A, Bhatt A, Gallup D, Anstrom K, Butler J, DeVore A, Felker G, Fudim M, Greene S, Hernandez A, Kelly J, Samsky M, Mentz R. Trajectory of Congestion Metrics by Ejection Fraction in Patients With Acute Heart Failure (from the Heart Failure Network). The American Journal Of Cardiology 2017, 120: 98-105. PMID: 28479167, PMCID: PMC5471496, DOI: 10.1016/j.amjcard.2017.03.249.
- Assessment of cardiac allograft systolic function by global longitudinal strain: From donor to recipientDeVore AD, Alenezi F, Krishnamoorthy A, Ersboll M, Samsky MD, Schulte PJ, Patel CB, Rogers JG, Milano CA, Velazquez EJ, Khouri MG. Assessment of cardiac allograft systolic function by global longitudinal strain: From donor to recipient. Clinical Transplantation 2017, 31: e12961. PMID: 28294407, DOI: 10.1111/ctr.12961.
- The impact of a failing right heart in patients supported by intra-aortic balloon counterpulsationKrishnamoorthy A, DeVore A, Sun J, Barnett A, Samsky M, Shaw L, Chiswell K, Patel C, Patel M. The impact of a failing right heart in patients supported by intra-aortic balloon counterpulsation. European Heart Journal Acute Cardiovascular Care 2016, 6: 709-718. PMID: 27230622, DOI: 10.1177/2048872616652262.
- Getting to a Man's Heart through His ColonSamsky MD, DeVore AD, Durkin M, Stout JE, Velazquez EJ, Milano CA. Getting to a Man's Heart through His Colon. Texas Heart Institute Journal 2016, 43: 168-70. PMID: 27127437, PMCID: PMC4845564, DOI: 10.14503/thij-14-4946.
- Prognostic Implications of Long-Chain Acylcarnitines in Heart Failure and Reversibility With Mechanical Circulatory SupportAhmad T, Kelly JP, McGarrah RW, Hellkamp AS, Fiuzat M, Testani JM, Wang TS, Verma A, Samsky MD, Donahue MP, Ilkayeva OR, Bowles DE, Patel CB, Milano CA, Rogers JG, Felker GM, O’Connor C, Shah SH, Kraus WE. Prognostic Implications of Long-Chain Acylcarnitines in Heart Failure and Reversibility With Mechanical Circulatory Support. Journal Of The American College Of Cardiology 2016, 67: 291-299. PMID: 26796394, PMCID: PMC5429585, DOI: 10.1016/j.jacc.2015.10.079.
- Liver function tests in patients with acute heart failure and associated outcomes: insights from ASCEND‐HFSamsky M, Dunning A, DeVore A, Schulte P, Starling R, Tang W, Armstrong P, Ezekowitz J, Butler J, McMurray J, Teerlink J, Voors A, Metra M, Mentz R, O'Connor C, Patel C, Hernandez A. Liver function tests in patients with acute heart failure and associated outcomes: insights from ASCEND‐HF. European Journal Of Heart Failure 2015, 18: 424-432. PMID: 26707029, DOI: 10.1002/ejhf.440.
- Elevated Total Bilirubin on Admission is a Marker of Worse 30- and 180-Day Outcomes for Patients With Acute HF: Insights From ASCEND-HFSamsky M, Dunning A, Schulte P, DeVore A, Mentz R, Patel C, Starling R, Teerlink J, Tang W, Armstrong P, Ezekowitz J, Metra M, Voors A, McMurray J, Butler J, O'Connor C, Hernandez A. Elevated Total Bilirubin on Admission is a Marker of Worse 30- and 180-Day Outcomes for Patients With Acute HF: Insights From ASCEND-HF. Journal Of Cardiac Failure 2015, 21: s120-s121. DOI: 10.1016/j.cardfail.2015.06.346.
- Comparison of 2-Year Outcomes of Extended Criteria Cardiac Transplantation Versus Destination Left Ventricular Assist Device Therapy Using Continuous FlowDaneshmand M, Krishnamoorthy A, Samsky M, Felker G, Pura J, Lokhnygina Y, Hernandez A, Rosenberg P, Blue L, Schroder J, Rogers J, Milano C, Patel C. Comparison of 2-Year Outcomes of Extended Criteria Cardiac Transplantation Versus Destination Left Ventricular Assist Device Therapy Using Continuous Flow. The American Journal Of Cardiology 2015, 116: 573-579. PMID: 26092273, DOI: 10.1016/j.amjcard.2015.05.016.
- Abstract 15556: Effects of Left Ventricular Assist Device Support on microRNA LevelsWang T, O’Brien E, Samsky M, Rogers J, Hernandez A, Bowles D, Felker G, Patel C, Ahmad T. Abstract 15556: Effects of Left Ventricular Assist Device Support on microRNA Levels. Circulation 2014, 130 DOI: 10.1161/circ.130.suppl_2.15556.
- Effects of Left Ventricular Assist Device Support on Biomarkers of Cardiovascular Stress, Fibrosis, Fluid Homeostasis, Inflammation, and Renal InjuryAhmad T, Wang T, O'Brien EC, Samsky MD, Pura JA, Lokhnygina Y, Rogers JG, Hernandez AF, Craig D, Bowles DE, Milano CA, Shah SH, Januzzi JL, Felker GM, Patel CB. Effects of Left Ventricular Assist Device Support on Biomarkers of Cardiovascular Stress, Fibrosis, Fluid Homeostasis, Inflammation, and Renal Injury. JACC Heart Failure 2014, 3: 30-39. PMID: 25447345, DOI: 10.1016/j.jchf.2014.06.013.
- Clinical Characteristics and Long Term Outcomes in Septuagenarians Undergoing Cardiac TransplantationCooper L, Patel C, Schulte P, Kelly J, Samsky M, Felker G, Milano C, Rogers J. Clinical Characteristics and Long Term Outcomes in Septuagenarians Undergoing Cardiac Transplantation. Journal Of Cardiac Failure 2014, 20: s33. DOI: 10.1016/j.cardfail.2014.06.095.
- Ten-Year Experience With Extended Criteria Cardiac TransplantationSamsky M, Patel C, Owen A, Schulte P, Jentzer J, Rosenberg P, Felker G, Milano C, Hernandez A, Rogers J. Ten-Year Experience With Extended Criteria Cardiac Transplantation. Circulation Heart Failure 2013, 6: 1230-1238. PMID: 24088293, PMCID: PMC4618320, DOI: 10.1161/circheartfailure.113.000296.
- Cardiohepatic Interactions in Heart Failure An Overview and Clinical ImplicationsSamsky M, Patel C, DeWald T, Smith A, Felker G, Rogers J, Hernandez A. Cardiohepatic Interactions in Heart Failure An Overview and Clinical Implications. Journal Of The American College Of Cardiology 2013, 61: 2397-2405. PMID: 23603231, DOI: 10.1016/j.jacc.2013.03.042.
- Abstract 19469: Outcomes in Extended-Criteria Caradiac Transplantation: A 10-Year ExperienceOwen A, Samsky M, Patel C, Hernandez A, Jentzer J, Schulte P, Felker G, Rosenberg P, Milano C, Rogers J. Abstract 19469: Outcomes in Extended-Criteria Caradiac Transplantation: A 10-Year Experience. Circulation 2012, 126 DOI: 10.1161/circ.126.suppl_21.a19469.
- CHARACTERIZING RENAL FUNCTION IN STANDARD AND EXTENDED CRITERIA CARDIAC TRANSPLANT PATIENTS: A 10-YEAR EXPERIENCESamsky M, Patel C, Hernandez A, Felker G, Rosenberg P, Milano C, Rogers J. CHARACTERIZING RENAL FUNCTION IN STANDARD AND EXTENDED CRITERIA CARDIAC TRANSPLANT PATIENTS: A 10-YEAR EXPERIENCE. Journal Of The American College Of Cardiology 2012, 59: e925. DOI: 10.1016/s0735-1097(12)60926-7.